PubRank

F Cardenal

Author PubWeight™ 17.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997 2.19
2 Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients. Ann Oncol 2005 1.51
3 Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial. J Clin Oncol 2003 1.11
4 Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung Cancer 2011 1.01
5 A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. Ann Oncol 2010 1.00
6 Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer. Lung Cancer 2004 0.98
7 A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. Ann Oncol 2010 0.92
8 Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer. Cancer Chemother Pharmacol 2012 0.86
9 Typhlitis associated with docetaxel treatment. J Natl Cancer Inst 1996 0.84
10 Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer. J Natl Cancer Inst 1997 0.84
11 Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer. Br J Cancer 2006 0.84
12 Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer. Lung Cancer 2000 0.81
13 Extrapyramidal reaction associated with ondansetron. Eur J Cancer 1993 0.79
14 Preoperative high-dose cisplatin versus moderate-dose cisplatin combined with ifosfamide and mitomycin in stage IIIA (N2) non small-cell lung cancer: results of a randomized multicenter trial. Clin Lung Cancer 2000 0.79
15 Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized study. Am J Clin Oncol 2000 0.78
16 Etoposide-related acral erythema. Cancer Chemother Pharmacol 1994 0.78
17 [Superior vena cava syndrome due to tuberculous mediastinal fibrosis. Report of two cases (author's transl)]. Med Clin (Barc) 1979 0.76
18 [The long-term results in small-cell lung cancer]. Med Clin (Barc) 1993 0.75
19 [Chemoprevention in cancer of the head and neck]. Acta Otorrinolaringol Esp 1997 0.75
20 Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy. Cancer Radiother 2007 0.75
21 Cytomegalovirus colitis in a patient with small-cell lung cancer. J Intern Med 1994 0.75
22 [Germinal tumors of the testis. A caseload and review of the literature]. Actas Urol Esp 1991 0.75
23 [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients]. Rev Clin Esp 1994 0.75
24 Recent features of the WHO programme for disability prevention in the African region. Int Rehabil Med 1981 0.75
25 Sarcomatoid renal cell carcinoma: a case of spontaneous regression of metastases. Eur Urol 1993 0.75
26 [Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor]. An Med Interna 1995 0.75
27 [Carcinomatous leptomeningitis as a complication of solid tumors. Presentation of 17 cases]. Neurologia 1990 0.75